These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2413306)

  • 1. Clinical evaluation of the vasodilator MDL-899 in patients with essential hypertension.
    Elliott HL; Campbell L; Sumner DJ; Reid JL
    J Cardiovasc Pharmacol; 1985; 7(5):948-52. PubMed ID: 2413306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.
    Bianchetti MG; Boehringer K; Weidmann P; Link L; Schiffl H; Ziegler WH
    Eur J Clin Pharmacol; 1982 Oct; 23(4):289-96. PubMed ID: 6129141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of endralazine (BO22708), a new vasodilator, in essential hypertension.
    Elliott HL; McLean K; Sumner DJ; Donnelly RJ; Reid JL
    Clin Exp Hypertens A; 1982; 4(8):1409-18. PubMed ID: 6749347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic studies in normal volunteers with MDL-899, a new arteriolar vasodilator.
    Howden CW; Elliott HL; Lawrie CB; Reid JL
    J Cardiovasc Pharmacol; 1983; 5(4):552-6. PubMed ID: 6193350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prizidilol (SK & F 92657), a new vasodilator with beta-blocking properties in the treatment of essential hypertension.
    Lüscher T; Havelka J; Greminger P; Tuma J; Täuber M; Siegenthaler W; Vetter W
    Eur J Clin Pharmacol; 1982; 23(5):411-5. PubMed ID: 6129980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prizidilol, a combined vasodilatory and beta-adrenoceptor blocking drug, in primary hypertension. A long-term efficacy, tolerance and pharmacokinetic study.
    Karlberg BE; Larsson R; Ohman KP; Norlander B; Wirsen A; Hed J; Lundh BL; Flock A
    Eur J Clin Pharmacol; 1983; 25(2):179-86. PubMed ID: 6138257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endralazine, a new peripheral vasodilator. Evaluation of safety and efficacy over a 3 year period.
    Bogers WA; Meems L
    Eur J Clin Pharmacol; 1983; 24(3):301-5. PubMed ID: 6861845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in blood pressure, fluid volumes and glomerular filtration rate during long-term treatment with prizidilol, an antihypertensive drug with combined vasodilatator and beta-adrenoceptor blocking actions.
    Andersen GS; Hartling OJ; Hein HO; Leth A
    Dan Med Bull; 1985 Oct; 32(5):280-3. PubMed ID: 2865088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of the new vasodilator carprazidil and minoxidil in the treatment of moderate to severe hypertension.
    Bianchetti MG; Weidmann P; Boehringer K; Link L; Schiffl H; Beretta-Piccoli C; Colombo JP
    Eur J Clin Pharmacol; 1982; 23(6):483-9. PubMed ID: 7160416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxdralazine, a new peripheral vasodilator, combined with propranolol and hydrochlorothiazide: a rational approach to antihypertensive treatment.
    Bartoli E; Faedda R; Arras S; Satta A; Soggia G
    J Clin Pharmacol; 1979; 19(11-12):751-7. PubMed ID: 536472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension.
    Ajayi AA; Elliott HL; Reid JL
    Br J Clin Pharmacol; 1986 Aug; 22(2):167-75. PubMed ID: 3019375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive efficacy of a new long acting hydralazine like vasodilator, ISF 2469 in combination with a betablocker and a diuretic.
    van Brummelen P; Bühler FR; Kiowski W; Bolli P; Bertel O
    Int J Clin Pharmacol Biopharm; 1979 Oct; 17(10):380-5. PubMed ID: 40887
    [No Abstract]   [Full Text] [Related]  

  • 13. Cadralazine, a new vasodilator, in addition to a beta-blocker for long-term treatment of hypertension.
    Salvadeo A; Villa G; Segagni S; Piazza V; Picardi L; Romano M; Parini J
    Arzneimittelforschung; 1985; 35(3):623-5. PubMed ID: 2859865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of cilazapril, a new angiotensin-converting enzyme inhibitor.
    Goldszer RC; Rodriguez R; Solomon HS
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):300S-302S. PubMed ID: 2970856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prizidilol, an antihypertensive with precapillary vasodilator and beta-adrenoceptor blocking actions, in primary hypertension.
    Larsson R; Karlberg BE; Norlander B; Wirsén A
    Clin Pharmacol Ther; 1981 May; 29(5):588-93. PubMed ID: 6111409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of prazosin and verapamil in the treatment of essential hypertension.
    Elliott HL; Meredith PA; Campbell L; Reid JL
    Clin Pharmacol Ther; 1988 May; 43(5):554-60. PubMed ID: 3284690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effect of prizidilol.
    Andrén L; Hansson L; Svensson A
    J Cardiovasc Pharmacol; 1983; 5(5):898-900. PubMed ID: 6195483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.
    Ishiguro K; Hayashi K; Sasamura H; Sakamaki Y; Itoh H
    Hypertension; 2009 Jan; 53(1):83-9. PubMed ID: 19047581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive and humoral effects of nifedipine in essential hypertension uncontrolled by hydrochlorothiazide alone.
    Opsahl JA; Halstenson CE; Abraham PA
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):828-33. PubMed ID: 2686710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacological studies with the vasodilator endralazine in normotensive subjects and essential hypertensives.
    Elliott HL; Meredith PA; Howden CW; Lawrie CB; Reid JL
    Int J Clin Pharmacol Res; 1984; 4(1):61-9. PubMed ID: 6469433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.